Hims & Hers Health (HIMS) Cash & Current Investments (2019 - 2026)

Hims & Hers Health's (HIMS) quarterly Cash & Current Investments came in at $750.9 million in Q1 2026, up 132.71% year-on-year from $322.7 million in Q1 2025, and up 30.02% quarter-over-quarter from $577.5 million in Q4 2025.

Hims & Hers Health (HIMS) Cash & Current Investments (2019 - 2026) Analysis & Trends

Hims & Hers Health has disclosed Cash & Current Investments across 8 years of filings, most recently posting $750.9 million for Q1 2026.

  • Cash & Current Investments for Q1 2026 came in at $750.9 million, up 132.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $750.9 million (up 132.71% YoY), and the FY2025 annual result was $577.5 million, up 92.34% from the prior year.
  • Cash & Current Investments came in at $750.9 million for Q1 2026 at Hims & Hers Health, up from $577.5 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $1.1 billion in Q2 2025 to a low of $179.6 million in Q4 2022.
  • The 5-year median for Cash & Current Investments is $221.0 million (2023), against an average of $352.8 million.
  • Across the five-year window, Cash & Current Investments sank 38.56% in 2022 and soared 403.59% in 2025, its largest moves.
  • Hims & Hers Health's Cash & Current Investments stood at $179.6 million in 2022, then rose by 23.02% to $221.0 million in 2023, then soared by 35.87% to $300.3 million in 2024, then jumped by 92.34% to $577.5 million in 2025, then soared by 30.02% to $750.9 million in 2026.
  • The last three Cash & Current Investments figures came in at $750.9 million (Q1 2026), $577.5 million (Q4 2025), and $629.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 3.74 Bn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 1.94 Bn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 2.15 Bn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn 77.77 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 1.32 Bn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn 428.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn 511.86 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 498.58 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn 750.88 Mn
10 Liquidia 5.74 Bn 5.52 Bn 121.79 Mn 222.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 750.88 Mn
Dec 31, 2025 577.49 Mn
Sep 30, 2025 629.74 Mn
Jun 30, 2025 1.14 Bn
Mar 31, 2025 322.67 Mn
Dec 31, 2024 300.25 Mn
Sep 30, 2024 254.07 Mn
Jun 30, 2024 227.29 Mn
Mar 31, 2024 203.59 Mn
Dec 31, 2023 220.98 Mn
Sep 30, 2023 212.50 Mn
Jun 30, 2023 193.14 Mn
Mar 31, 2023 184.39 Mn
Dec 31, 2022 179.63 Mn
Sep 30, 2022 198.39 Mn
Jun 30, 2022 194.98 Mn
Mar 31, 2022 203.05 Mn
Dec 31, 2021 247.27 Mn
Sep 30, 2021 252.43 Mn
Jun 30, 2021 317.32 Mn